Does preoperative CA-125 cutoff value and percent reduction in CA-125 levels correlate with surgical and survival outcome after neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer? – Our experience from a tertiary cancer institute
Aim: The aim of the study is to evaluate percent fall in CA-125 levels after neoadjuvant chemotherapy (NAC) and preoperative CA-125 value to predict surgical and survival outcomes in women with advanced-stage epithelial ovarian cancer (EOC). Methods: A retrospective review of 406 women receiving NAC...
Main Authors: | Monisha Gupta, Shilpa Mukesh Patel, Ruchi Arora, Rajneesh Tiwari, Pariseema Dave, Ava Desai, Meeta Mankad |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2020-01-01
|
Series: | South Asian Journal of Cancer |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.4103/sajc.sajc_53_17 |
Similar Items
-
Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer
by: Kazuto Nakamura, et al.
Published: (2020-08-01) -
Preoperative serum CA-125 level as a predictor for the extent of cytoreduction in patients with advanced stage epithelial ovarian cancer
by: Merlo Sebastjan, et al.
Published: (2021-08-01) -
Clinical study of a CT evaluation model combined with serum CA125 in predicting the treatment of newly diagnosed advanced epithelial ovarian cancer
by: Lu Qin, et al.
Published: (2018-06-01) -
NEOADJUVANT CHEMOTHERAPY FOR EPITHELIAL OVARIAN CANCER. MODERN METHODS AND PATIENTS SELECTION CRITERIA
by: A. E. Solopova, et al.
Published: (2016-09-01) -
Influence of Neoadjuvant CAF Chemotherapy on Serum TSGF, CA15-3 and CA125 in Patients with Breast Cancer
by: hang-xiao ZHAO, et al.
Published: (2016-09-01)